Epidemiology

To curb future pandemics, we must address the ongoing challenges with global vaccine distribution.

Should we still be concerned about omicron? What do we know now? Hopkins virologist Andy Pekosz gives an update in a Q&A. It’s not all bad news—but there are still many unknowns.

 A couple long years into the COVID-19 pandemic, it can be easy to think of it as a once-in-a-generation event. Instead, the pandemic should be viewed as “a warning shot” in the face of mounting biological threats  that countries still aren’t prepared to meet, according to…

Omicron is a new variant of concern, but we’re more prepared to mitigate extreme effects than we were at the beginning of the pandemic.

In a baseline scenario, the researchers project a rise in the ART-using population from about 670,000 in 2020 to nearly 910,000 by the end of 2030 if current trends in new HIV infections persist.